Application of day surgery management for lung cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000034999

Enrollment

Unknown

Registered

2020-07-27

Start date

2020-08-25

Completion date

Unknown

Last updated

2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Day surgery group: day surgery management of l ung cancer

In-hospital group:In-hospital management of l ung cancer

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Subjects under 50 years old; 2. Patients with primary lung cancer diagnosed by pathological examination; 3. Patients with segmental and lobar resection plus systematic lymph node dissection; 4. Patients with complete clinical data and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who received preoperative chemoradiotherapy; 2. Patients with postoperative bleeding or persistent air leakage requiring reoperation.

Design outcomes

Primary

Measure	Time frame
Postoperative complications;Postoperative adverse reactions;	—

Countries

China

Contacts

Public ContactGuowei Che

West China Hospital of Sichuan University

cheguowei_hx@aliyun.com+86 18980601890

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026